<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03395639</url>
  </required_header>
  <id_info>
    <org_study_id>DU176b-C-U313</org_study_id>
    <secondary_id>2017-000475-90</secondary_id>
    <nct_id>NCT03395639</nct_id>
  </id_info>
  <brief_title>Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease</brief_title>
  <official_title>An Open-label, Randomised, Parallel-group, Multicentre, Observational Trial to Evaluate Safety and Efficacy of Edoxaban Tosylate in Children From 38 Weeks Gestational Age to Less Than 18 Years of Age With Cardiac Diseases at Risk of Thromboembolic Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daiichi Sankyo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Daiichi Sankyo, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A committee will judge the safety and effectiveness of edoxaban and the regular treatment
      (standard of care).

      All children in the study will receive free treatment. They will have a 2 in 3 chance to
      receive edoxaban, and a 1 in 3 chance to receive the standard of care for preventing blood
      clots.

      The study will find out if edoxaban is safer and more effective than the standard of care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective is to compare the safety of edoxaban with the standard of care (SOC) in
      pediatric subjects with cardiac diseases at risk of thromboembolic complications who need
      primary or secondary anticoagulant prophylaxis with regard to the combination of major and
      clinically relevant non-major (CRNM) bleeding per International Society on Thrombosis and
      Haemostasis [ISTH] definition.

      The key secondary objective is to compare the efficacy of edoxaban against SOC with regard to
      the development of symptomatic thromboembolic events (TE) in the systemic arterial or venous
      pathways including deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, intracardiac
      thrombus and myocardial infarction (MI), and asymptomatic intracardiac thrombus identified by
      cardiac imaging.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2017</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with combined bleeding events within the main treatment period</measure>
    <time_frame>within 4 months (3-month Main Treatment Period + 30-day follow-up)</time_frame>
    <description>Combined bleeding events include major and clinically-relevant non-major (CRNM) bleeding events per International Society on Thrombosis and Haemostasis (ISTH) definition occurring within the main treatment period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants with combined bleeding events during the entire trial (from first to the last dose plus 30 days)</measure>
    <time_frame>within 13 months (3-month Main Treatment Period + 9-month Extension Period + 30-day follow-up)</time_frame>
    <description>Combined bleeding events include major and clinically-relevant non-major (CRNM) bleeding events per International Society on Thrombosis and Haemostasis (ISTH) definition occurring on treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with symptomatic thromboembolic events (TE) in the systemic arterial or venous pathways</measure>
    <time_frame>within 4 months</time_frame>
    <description>Symptomatic thromboembolic events (TE) in the systemic arterial or venous pathways include deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, intracardiac thrombus and myocardial infarction (MI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with symptomatic thromboembolic events (TE) in the systemic arterial or venous pathways</measure>
    <time_frame>within 13 months</time_frame>
    <description>Symptomatic thromboembolic events (TE) in the systemic arterial or venous pathways include deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, intracardiac thrombus and myocardial infarction (MI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who died as a result of TE between randomization and the date of the last dose of study drug plus 30 days</measure>
    <time_frame>within 13 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who died as a result of any cause between randomization and the date of the last dose of study drug plus 30 days</measure>
    <time_frame>within 13 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cardiac Disease</condition>
  <arm_group>
    <arm_group_label>Edoxaban</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two out of three participants will be randomized for treatment with edoxaban solution or tablets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care (SOC)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One out of three participants will be randomized for treatment with the institution's SOC regimen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Edoxaban</intervention_name>
    <description>Edoxaban 15 mg or 30 mg tablets for participants 12 to &lt;18 years of age, or 60 mg edoxaban suspension (dosed as mg/kg) for participants under 12 years of age (and optionally, 12 or older), for oral administration</description>
    <arm_group_label>Edoxaban</arm_group_label>
    <other_name>Lixiana</other_name>
    <other_name>Savaysa</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard of Care (SOC)</intervention_name>
    <description>Standard of care could include low molecular weight heparin (LMWH) and/or VKA according to the clinical site's SOC treatment regimen</description>
    <arm_group_label>Standard of Care (SOC)</arm_group_label>
    <other_name>Warfarin/heparin</other_name>
    <other_name>Enoxaparin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Is a child with cardiac disease who is at risk for thromboembolic complications and
             requires at least 3 months antithrombotic anticoagulant prophylaxis

        Either one of the following:

          1. a child with cardiac disease who has a history of cardiac shunt occlusion/thrombosis,
             with shunt still in place (secondary prevention).

             OR

          2. a child with cardiac disease who requires (including those already taking, and those
             not yet taking) anticoagulation for primary prevention of TE.

        Cardiac conditions known to significantly increase the risk of thrombosis (hence,
        indications for primary TE prevention) are defined in Antithrombotic Therapy and Prevention
        of Thrombosis. Some examples of cardiac conditions at risk of thrombosis are Fontan
        surgery, heart failure, Kawasaki disease, and Blalock-Taussig and Glenn surgery.

          -  Is a male or female child between 1 and &lt;18 years of age (children between 38 weeks
             gestational age and 1 year of age will be included in the study, however, only after
             the safety and efficacy data of 50 subjects between 1 and &lt;18 years of age in the
             edoxaban arm have been evaluated at the end of the 3-month treatment period)

          -  Has parent(s)/legal guardian(s) or legally acceptable representative who is informed
             and provides signed consent for the child, to participate in the study with edoxaban
             treatment. Pediatric participants with appropriate intellectual maturity will be
             required to sign an assent form in addition to the signed informed consent from the
             parent(s)/legal guardian(s) or any legally acceptable representative.

          -  If a female subject of childbearing potential, tests negative for pregnancy at
             Screening and consents to avoid becoming pregnant by using a locally approved
             contraception method throughout the study

        Exclusion Criteria:

          -  Has evidence of symptomatic venous or arterial thrombosis and/or asymptomatic
             intracardiac thrombosis confirmed by a transthoracic echocardiogram during study
             screening period

          -  Has mechanical heart valve(s)

          -  Has active bleeding or high risk of bleeding contraindicating treatment with
             anticoagulant

          -  Takes antithrombotic therapy (other than low-dose aspirin) that is not
             protocol-related

          -  Administration of rifampin is prohibited during the study and subjects on concomitant
             use of rifampin are excluded

          -  Has any hepatic disease associated with coagulopathy leading to a clinically relevant
             bleeding risk

          -  Has estimated glomerular filtration rate (eGFR) &lt;30% of normal for age and size

          -  Has stage 2 hypertension defined as blood pressure systolic and/or diastolic confirmed
             &gt;99th percentile plus 5 mmHg

          -  Has thrombocytopenia or life expectancy less than three months

          -  Has had Fontan procedure with a history of or signs/symptoms suggestive of
             protein-losing enteropathy

          -  Is pregnant or breastfeeding

          -  Has a contraindication to the use of heparin and/or vitamin K antagonist (VKA)

          -  Has any condition that, as judged by the Investigator, would place the participant at
             increased risk of harm if he/she participated in the study, including contraindicated
             medications identified in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Study Leader</last_name>
    <role>Study Director</role>
    <affiliation>Daiichi Sankyo, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>205-638-2018</phone>
      <email>khock@peds.uab.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cardon Childrens Medical Center</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nurse Administrator</last_name>
      <phone>480-412-5561</phone>
      <email>Stephanie.Blythe@bannerhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center (ECG)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>424-315-2297</phone>
      <email>Jennifer.chang3@cshs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UC Davis Children's Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>800-282-3284</phone>
      <email>anjali.pawar@ucdmc.ucdavis.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California-San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>415-514-1489</phone>
      <email>Emma.Burdekin@ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida College of Medicine</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>352-294-8714</phone>
      <email>dalylc@ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John's Hopkins All Children's Hospital</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>727-767-6468</phone>
      <email>jade.hanson@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>312-227-1549</phone>
      <email>kvanthof@luriechildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>312-563-2134</phone>
      <email>Sawsan_M_Awad@rush.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Ped CAR</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>859-323-2737</phone>
      <email>dross3@email.uky.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>314-454-6095</phone>
      <email>canter@wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mt Sinai Pediatric Cardiology</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>212-241-8662</phone>
      <email>anne.barnes@mssm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Novant Health Heart and Vascular institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>704-316-1220</phone>
      <email>mbbrothers@novanthealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke Department of Pediatrics</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>919-668-3910</phone>
      <email>Melissa.harward@duke.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>East Carolina Heart Institute @ ECU</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>252-744-2161</phone>
      <email>stanleyt18@ecu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>336-713-7362</phone>
      <email>nnjackso@wakehealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OU Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>405-271-4411</phone>
      <email>charles-sperrazza@ouhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>434-243-0910</phone>
      <email>crb3y@virginia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic Department of Pediatrics</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>540-985-9934</phone>
      <email>Kehirt@carilionclinic.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>206-884-1317</phone>
      <email>Jennifer.Cox@seattlechildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kepler Universitätsklinikum Med Campus IV</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+43 576808424817</phone>
      <email>Andreas.Tulzer@kepleruniklinikum.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McMaster Children's Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>76054</phone_ext>
      <email>hamiltonko@hhsc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Sainte-Justine</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>514-315-4931</phone>
      <phone_ext>2152</phone_ext>
      <email>nagib.dahdah.hsj@ssss.gouv.qc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre/Glen Site/Montreal Children's Hospital</name>
      <address>
        <city>Pierrefonds</city>
        <state>Quebec</state>
        <zip>H9H 4Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>514-412-4400</phone>
      <phone_ext>24445</phone_ext>
      <email>christine.sabapathy@mcgill.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital Zadar</name>
      <address>
        <city>Zadar</city>
        <zip>23000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+38523505119</phone>
      <email>rkarlo01@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Centre Zagreb</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+385 098212841</phone>
      <email>ivan.malcic1@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zagazig University Hospital</name>
      <address>
        <city>Zagazig</city>
        <state>Al Sharkeya</state>
        <zip>44519</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+20 35840476</phone>
      <email>m_a_badr2005@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alexandria Clinical Research Center, Faculty of Medicine</name>
      <address>
        <city>Alexandria</city>
        <zip>21131</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+20 1227392947</phone>
      <email>drhoda@doctor.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kasr Elainy School of Medicine, Abo Elreesh Hospital (Japanese Hospital), Ali Basha Ibrahim ST Faculty of Medicine Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+20 1222152161</phone>
      <email>dr.hala_hamza@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ain Shams University Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11566</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+20 1000864343</phone>
      <email>elalfym@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Suez Canal University Hospital</name>
      <address>
        <city>Ismailia</city>
        <zip>41522</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+20 1221028158</phone>
      <email>aymansabry205@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mansoura University Hospital</name>
      <address>
        <city>Mansourah</city>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+20502238673</phone>
      <email>ak_mans@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Cardiologique Haut-Leveque, Service des maladies cardiovasculaires congénitales</name>
      <address>
        <city>Pessac</city>
        <state>Gironde</state>
        <zip>33600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+33 557656666</phone>
      <email>pierre-emmanuel.seguela@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital des enfants, bâtiment modulaire</name>
      <address>
        <city>Toulouse cedex 9</city>
        <state>Haute Garonne</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33 567771095</phone>
      <email>auriol.f@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <state>Herault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33 467336632</phone>
      <email>Hamouda-abassi@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Pontchaillou</name>
      <address>
        <city>Rennes cedex 09</city>
        <state>Ille Et Vilaine</state>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33 299289812</phone>
      <email>david.vallee@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pediatric Cardiology Department, Hospital Necker Enfants Malades, APHP, Université Paris Descartes</name>
      <address>
        <city>Paris cedex 15</city>
        <state>Paris</state>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+33 144494344</phone>
      <email>damien.bonnet@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Stuttgart-Olgahospital</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden Wuerttemberg</state>
        <zip>70174</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+49 71127872441</phone>
      <email>u.schweigmann@klinikum-stuttgart.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pediatric Heart Center Giessen</name>
      <address>
        <city>Giessen</city>
        <state>Hessen</state>
        <zip>35385</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+49 64198543461</phone>
      <email>Svenja.krueck@paediat.med.uni-giessen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsmedizin Goettingen</name>
      <address>
        <city>Göttingen</city>
        <state>Niedersachsen</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+49 5513966203</phone>
      <email>verena.gravenhorst@med.uni-goettingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charite - Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+49 3045932845</phone>
      <email>kschmitt@dhzb.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gottsegen Gyorgy Orszagos Kardiologiai Intezet</name>
      <address>
        <city>Budapest</city>
        <zip>1096</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+36 12157441</phone>
      <email>szatmari@kardio.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Svabhegy Plusz Gyermek-Egeszsegugyi Kozpont Kft.</name>
      <address>
        <city>Budapest</city>
        <zip>1721</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+36 204000360</phone>
      <email>balint.laszlo@svabhegy.eu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont</name>
      <address>
        <city>Szeged</city>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+36 62545330</phone>
      <email>study.pedia@med.u-szeged.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sir Ganga Ram Hospital</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110060</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+91 9910104842</phone>
      <email>bedi.varinder@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nirmal Hospital Private Limited</name>
      <address>
        <city>Surat</city>
        <state>Gujarat</state>
        <zip>395002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+91 9979530073</phone>
      <email>drjashvant.patel@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Beer Sheva</city>
        <zip>8410101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+972 86243589</phone>
      <email>Ayeletpu@clalit.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+972 25645675</phone>
      <email>Joleenist@szmc.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hadassah University Hospital - Ein Kerem</name>
      <address>
        <city>Jerusalem</city>
        <zip>9112001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+972 26777511</phone>
      <email>hilay@hadassah.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>5265601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+927 35308010</phone>
      <email>oliana.Vazhgovky@sheba.health.gov.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Infantile Regina Margherita</name>
      <address>
        <city>Turin</city>
        <state>Torino</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+39 0113135787</phone>
      <email>paola.saracco@unito.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS</name>
      <address>
        <city>Genova</city>
        <zip>16147</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+39 1056361</phone>
      <email>alessandrorimini@ospedale-gaslini.ge.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+39 498211111</phone>
      <email>ornella.milanesi@unipd.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Pediatrico Bambino Gesù</name>
      <address>
        <city>Roma</city>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>'+39 668592579</phone>
      <email>antonella.santilli@opbg.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Heart Centre at the American University of Beirut Medical Center</name>
      <address>
        <city>Beirut</city>
        <zip>11-0236</zip>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>'+961 1350000</phone>
      <phone_ext>5865</phone_ext>
      <email>fbitar@aub.edu.lb</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hotel Dieu de France Hospital</name>
      <address>
        <city>Beirut</city>
        <zip>166830</zip>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>'+961 3434942</phone>
      <email>najibhanna@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Children's Memorial Health Institute, Al. Dzieci Polskich</name>
      <address>
        <city>Warszaw</city>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+48 228157370</phone>
      <email>oddzial.kardiologia@ipczd.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Szpital Specjalistyczny we Wroclawiu</name>
      <address>
        <city>Wroclaw</city>
        <zip>51-124</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+48 713270140</phone>
      <email>Kusa@wssk.wroc.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FSBI &quot;Scientific-research Institute for Complex Problems of Cardiovascular Disease&quot;</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+7 9043780533</phone>
      <email>zverevat25@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Federal State Autonomous Institution &quot;National Scientific and Practical Center for Children's Health&quot; of the Ministry of Health of the Russian Federation</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+7 4959671420</phone>
      <email>namazova@nczd.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LLC &quot;Multidisciplinary Center of Modern Medical Care &quot;Euromed&quot;</name>
      <address>
        <city>Omsk</city>
        <zip>644024</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+7 3812795030</phone>
      <email>tpertels@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FSBI Tomsk National Research Medical Center of the Russian Academy of Sciences</name>
      <address>
        <city>Tomsk</city>
        <zip>634050</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+7 3822511039</phone>
      <email>ivp@cardio-tomsk.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+34 934893000</phone>
      <email>dcalbert@vhebron.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erciyes University Medical Faculty</name>
      <address>
        <city>Edirne</city>
        <state>Kayseri</state>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+90 5325570052</phone>
      <email>turkanp@erciyes.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cukurova University Medical Faculty</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+90 3223386906</phone>
      <email>kyurdnur@cu.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hacettepe University Medical Faculty</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+90 5325263749</phone>
      <email>suleunal@hacettepe.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ankara Child Health and Diseases Hematology Oncology Education and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06110</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+90 5322574196</phone>
      <email>namikyozbek@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istanbul University Istanbul Medical Faculty</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+90 2124142000</phone>
      <email>zkarakas@istanbul.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ege University Faculty of Medicine Department of Child Health and Diseases</name>
      <address>
        <city>Izmir</city>
        <zip>35040</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+90 2323901017</phone>
      <email>Kaan.kavakli@ege.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tepecik Education and Training Hospital, Department of Pediatric Hematology and Oncology, Ministry of Health Izmir Tepecik, Training and Research Hospital</name>
      <address>
        <city>Izmir</city>
        <zip>35170</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+90 2324696969</phone>
      <email>barismalbora@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Izmir-Dr. Behçet Uz. Pediatric Diseases and Surgery Training and Research Hospital- Izmir Dr. Behcet Uz Cocuk Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi</name>
      <address>
        <city>Izmir</city>
        <zip>35210</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+90 5362013162</phone>
      <email>hasanagin@mynet.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Institution Dnipropetrovsk Regional Pediatric Clinical Hospital of Dnipropetrovsk Regional Council, State Institution Dnipropetrovsk Medical Academy of MoH of Ukraine</name>
      <address>
        <city>Dnipro</city>
        <zip>49100</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+380 677671524</phone>
      <email>Vdihtiar2017@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Healthcare Institution Regional Pediatric Clinical Hospital, Kharkiv National Medical University</name>
      <address>
        <city>Kharkiv</city>
        <zip>61093</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+380 506388992</phone>
      <email>margarytagonchar@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Higher State Educational Establishment of Ukraine &quot;Ukrainian Medical Stomatological Academy&quot;, Department of Pediatrics</name>
      <address>
        <city>Poltava</city>
        <zip>36011</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+380 503277023</phone>
      <email>drkryuchko@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vinnytsia Regional Children Clinical Hospital Dept of pediatrics #1 Vinnytsia M.I. Pyrogov NMU</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+380 432552043</phone>
      <email>yulia_tokarchuk@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>SW3 6HP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+44 3301288430</phone>
      <email>p.daubeney@rbht.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Glenfield Hospital</name>
      <address>
        <city>Leicester</city>
        <state>Leicestershire</state>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>+44 1162563904</phone>
      <email>frances.bu'lock@uhl-tr.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ward 2B, Royal Hospital for Children</name>
      <address>
        <city>Glasgow</city>
        <state>Strathclyde</state>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nurse Administrator</last_name>
      <phone>+44 1414524624</phone>
      <email>alison.spence2@ggc.scot.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Canada</country>
    <country>Croatia</country>
    <country>Egypt</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Lebanon</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2018</study_first_submitted>
  <study_first_submitted_qc>January 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2018</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Cardiac disease with potential for thromboembolic complications</keyword>
  <keyword>Prophylactic treatment</keyword>
  <keyword>Anticoagulant drugs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edoxaban</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified individual participant data (IPD) and applicable supporting clinical trial documents may be available upon request at https://www.clinicalstudydatarequest.com//. In cases where clinical trial data and supporting documents are provided pursuant to our company policies and procedures, Daiichi Sankyo will continue to protect the privacy of our clinical trial participants. Details on data sharing criteria and the procedure for requesting access can be found at this web address: https://www.clinicalstudydatarequest.com/Study-Sponsors/Study-Sponsors-DS.aspx</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

